REFERENCES
- Carmel R, Green R, Rosenblatt D S, Watkins D. Update on cobalamin, folate, and homocysteine. Hematology 2003; 2003: 62–81, [CSA]
- Howard R, Frieden I, Crawford D. Methylmalonic academia, Cobalamin C type, presenting with cutaneous manifestations. Arch Dermatol. 1997; 133: 1563–1566, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kind T, Levy J, Lee M, Kaicker S, Nicholson J F, Kane S A. Cobalamin C disease presenting as hemolytic-uremic syndrome in the neonatal period. J Pediatr Hematol Oncol. 2002; 24: 327–329, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Andersson H, Shapira E. Biochemical and clinical response to hydroxocobalamin versus cyanocobalamin treatment in patients with methylmalonic academia and homocystinuria (cblC). J Pediatr. 1998; 132: 121–124, [PUBMED], [INFOTRIEVE], [CSA]
- HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society. Med Pediatr Oncol. 1997; 28: 342–347, [CSA], [CROSSREF]
- Duyal M, Fenneteau O, Doireau V. Intermittent hemophagocytic lymphohistiocytosis is a regular feature of lysinuric protein intolerance. J Pediatr. 1999; 134: 236–239, [CSA]
- Bader-Meunier B, Parez N, Muller S. Treatment of hemophagocytic lymphohistiocytosis with cyclosporine A and steroid in a boy with lysinuric protein intolerance. J Pediatr. 2000; 136: 134, [PUBMED], [INFOTRIEVE], [CSA]